Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 121 B, Issue 1, 2003, Pages 50-54

  Kirley, Aiveen ^a,c   Lowe, Naomi ^a   Hawi, Ziarih ^a   Mullins, Celine ^a   Daly, Grainne ^a   Waldman, Irwin ^b   McCarron, Mary ^a   O'Donnell, Deirdre ^a   Fitzgerald, Michael ^a   Gill, Michael ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b EMORY UNIVERSITY   (United States)

^c ST JAMES S HOSPITAL   (Ireland)

Author keywords

Attention deficit hyperactivity disorder (ADHD); Dopamine transporter gene (DAT1); Drug response; Methylphenidate; Transmission disequilibrium test (TDT)

Indexed keywords

DOPAMINE TRANSPORTER; DOPAMINE TRANSPORTER 1; GENE PRODUCT; METHYLPHENIDATE; UNCLASSIFIED DRUG;

ADOLESCENT; ALLELISM; ARTICLE; ATTENTION DEFICIT DISORDER; DRUG SENSITIVITY; FEMALE; GENE; GENE DAT1; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE REPEAT; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT PLANNING;

EID: 0041819651     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20071     Document Type: Article

References (37)

1. Amara S, Kuhar M. 1993. Neurotransmitter transporters: Recent progress. Ann Rev Neurosci 16:73-93.
2. Angold A, Costello EJ. 2000. The child adolescent psychiatric assessment (CAPA). J Am Acad Child Adol Psychiatry 39:39-48.
3. Barkley RA. 1990. Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: Guilford.
4. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C. 1992. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder patterns of comorbidity in probands and relatives in psychiatrically and paediatrically referred samples. Arch Gen Psychiatry 49:728-738.
5. Cadoret RJ, Stewart MA. 1991. An adoption study of ADH/D and aggression and their relationship to adult antisocial personality. Comp Psychiatry 32:73-82.
6. Conners CK, Sitarenios G, Parker JD, Epstein JN. 1998. The revised Conners' Parent Rating Scale (CPRS-R): Factor structure, reliability, and criterion validity. J Abnorm Child Psychol 4:257-268.
7. Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE. 1995. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993-998.
8. Curran S, Mill J, Tahir E, Kent L, Richards S, Gould A. 2001. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry 6(4):425-428.
9. Daly G, Hawi Z, Fitzgerald M, Gill M. 1999. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH, and DRD5 to affected children. Mol Psychiatry 4:192-196.
10. Doucette-Stamm LA, Blakely DJ, Tian J, Mockus S, Mao JI. 1995. Population genetic study of the human dopamine transporter gene (DAT1). Genet Epidemiol 12:303-308.
11. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ. 1999. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354:9196.
12. Dresel S, Krause J, Krause K-H, LaFougere C, Brinkbaumer K, Kung HF. 2000. Attention deficit hyperactivity disorder: Binding of [[99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med 27:1518-1524.
13. Faraone SV, Biederman J, Milberger S. 1994. An exploratory study of ADHD among second-degree relatives of ADHD children. Biol Psychiatry 35:398-402.
14. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. 2001. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogen J 1:152-156.
15. Gill M, Daly G, Heron S. 1997. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 2:311-313.
16. Gjone H, Stevenson J, Sundet JM. 1996. Genetic influence on parent-reported attention related problems in Norwegian general population twin sample. J Am Acad Child and Adoles Psychiatry 35:588-596.
17. Gualtieri CT, Hicks RE, Patrick K. 1984. Clinical correlates of methylphenidate blood levels. Ther Drug Monit 6(4):379-392.
18. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG. 2000. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22(2):133-139.
19. Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB. 2000. Prediction of dopamine transporter binding availability by genotype: A preliminary report. Am J Psychiatry 157:1700-1703.
20. Kirley A, Hawi Z, Daly G, McCarron M, Mullins C, Millar N. 2002. Dopaminergic system genes in ADHD: Towards a biological hypothesis. Neuropsychopharmacology 27(4):607-619.
21. Krause KL, Dresel SH, Krause J, Kung HF, Tatsch K. 2000. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 285:107-110.
22. Levy F, Hat DA, McStephen M, Wood C, Waldman I. 1997. Attention deficit hyperactivity disorder: A category or continuum? J Am Acad Child and Adoles Psychiatry 36:737-744.
23. Martinez D, Gelernter J, Abi-Dargham A, van Dyck CH, Kegeles L, Innis RB. 2001. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 24(5):553-560.
24. Michaelhaugh SK, Fiskerstrand C, Lovejoy E, Bannon MJ, Quinn JP. 2001. The dopamine transportrt gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochemistry 79:1033-1038.
25. Mill J, Asherson P, Browes C, D'Souza U, Craig I. 2002. Expression of the dopamine transporter gene is regulated by the 3′-UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet (Neuropsychiatr Genet) 114(8):975-979.
26. Miller GM, Madras BK. 2002. Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 7:44-55.
27. Nakamura Y, Koyama K, Matsushima M. 1998. VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators. J Hum Genet 43:149-152.
28. Roman T, Szobot C, Martins S, Biederman J, Rohde LA, Hutz M. 2002. Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder. Pharmacogenetics 12:497-499.
29. Santosh PJ, Taylor E. 2000. Stimulant drugs. Eur Child Adolesc Psychiatry 9(Suppl 1):127-143.
30. Seeman P, Madras BK. 1998. Anti-hyperactivity medication: Methylphenidate and amphetamine. Mol Psychiatry 3:386-396.
31. Spencer T, Beiderman J, Wilens T, Harding M, O'Donnell D, Griffen S. 1996. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35(4):409-432.
32. Spielman RS, Ewens WJ. 1996. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Gen 59:983-989.
33. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS. 1998. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155:1325-1331.
34. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL. 1998. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 63:1767-1776.
35. Waldman ID, Robinson BF, Rowe DC. 1999. A logistic regression based extension of the TDT for continuous and categorical traits. Ann Hum Genet 63:329-340.
36. Winsberg BG, Comings DE. 1999. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response, J Am Acad Child Adolesc Psychiatry 38(12):1474-1477.
37. Zametkin AJ, Rapoport JL. 1987. Noradrenergic hypothesis of attention deficit disorder with hyperactivity: A critical review in psychopharmacology. In: Meltzer HY, editor. The third generation of progress. New York: Raven Press. pp 837-842.